Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence.
Bakhshinyan D, Adile AA, Liu J, Gwynne WD, Suk Y, Custers S, Burns I, Singh M, McFarlane N, Subapanditha MK, Qazi MA, Vora P, Kameda-Smith MM, Savage N, Desmond KL, Tatari N, Tran D, Seyfrid M, Hope K, Bock NA, Venugopal C, Bader GD, Singh SK.
Bakhshinyan D, et al. Among authors: burns i.
Sci Adv. 2021 Dec 10;7(50):eabi5568. doi: 10.1126/sciadv.abi5568. Epub 2021 Dec 8.
Sci Adv. 2021.
PMID: 34878832
Free PMC article.